A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
Yi‐Chao Zheng(Ministry of Education), Hong‐Min Liu(Kailuan General Hospital), Jinfeng Li(Hebei Medical University), Wen Zhao(Zhengzhou University), Wenjuan Zhou(Central South University), Xixin Wang(Anhui Medical University), Xiaojing Shi(Shandong University of Traditional Chinese Medicine), Zhiru Wang(Zhengzhou University), Jinlian Ma(Wenzhou Medical University), Bailing Jiang(Nanjing Tech University)
Cited by 181
Related Papers
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
|Molecular Cancer|2022|194
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling
|Journal of Biological Chemistry|2015|190